Retatrutide Archives | Fountain of Youth

Jan 07

Retatrutide: The Triple-Agonist Achieving Bariatric Surgery Weight Loss Benchmarks

Retatrutide: The Triple‑Agonist Approaching Bariatric Surgery Weight Loss

By Damian Williams Medical Weight Loss

Takeaways Retatrutide delivers near‑surgical levels of weight loss in early trials through its triple‑agonist mechanism. Phase III TRIUMPH studies will determine long‑term safety, durability, and real‑world impact across diverse patient groups. The drug…

Medical Weight Loss

Retatrutide: The Triple‑Agonist Approaching Bariatric Surgery Weight Loss

Medical Weight Loss

The Next Wave of Antibody Therapies: ActRIIA/B Inhibition for Muscle Preservation During Rapid Weight Loss

Takeaways ActRIIA/B inhibition shows promise in preserving lean muscle during rapid weight loss, unlike GLP-1 drugs alone. New therapies like LAE102 and dual ligand blockers aim to improve body composition without compromising function.…

Medical Weight Loss

Targeting Cancer: Groundbreaking Research on GLP‑1 Agonists Suppressing Obesity‑Associated Tumor Growth

Takeaways GLP‑1 and dual agonist drugs like tirzepatide have shown the ability to slow tumor growth in obesity‑linked cancers, especially in preclinical models. Early human data suggest a potential reduction in cancer risk…

CHECK OUT OUR BLOG HERE